Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Cervical Cancer

Free Subscription Articles published in Cancer Retrieve available abstracts of 41 articles: HTML format

Single Articles

April 2024
1. NIERENGARTEN MB
   Promising new treatment approaches for locally advanced cervical cancer.
   Cancer. 2024;130:1192.
   PubMed    
   
   
   March 2024
2. MEGHANI K, Puri P, Bazzett-Matabele L, Vuylsteke P, et al
   Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana.
   Cancer. 2024 Mar 26. doi: 10.1002/cncr.35289.
   PubMed     Abstract available
   
   
   
3. LEE H, Baeker Bispo J, Pal Choudhury P, Wiese D, et al
   Factors contributing to differences in cervical cancer screening in rural and urban community health centers.
   Cancer. 2024 Mar 25. doi: 10.1002/cncr.35265.
   PubMed     Abstract available
   
   
   
4. MICHEL AD, Fontenot HB, Fuzzell L, Brownstein NC, et al
   Attitudes toward the American Cancer Society's 2020 cervical cancer screening guidelines: A qualitative study of a national sample of US clinicians.
   Cancer. 2024 Mar 4. doi: 10.1002/cncr.35269.
   PubMed     Abstract available
   
   
   January 2024
5. 
   New test for detecting cervical adenocarcinoma.
   Cancer. 2024;130:10.
   PubMed    
   
   
   
6. BYTNAR JA, McGlynn KA, Nealeigh MD, Shriver CD, et al
   Cancer incidence in the US military: An updated analysis.
   Cancer. 2024;130:96-106.
   PubMed     Abstract available
   
   
   November 2023
7. 
   HPV testing in older women may improve cervical cancer prevention.
   Cancer. 2023;129:3518.
   PubMed    
   
   
   October 2023
8. KNISELY A, Ahmed J, Stephen B, Piha-Paul SA, et al
   Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies.
   Cancer. 2023 Oct 21. doi: 10.1002/cncr.35063.
   PubMed     Abstract available
   
   
   September 2023
9. VADAPARAMPIL ST, Fuzzell LN, Brownstein NC, Fontenot HB, et al
   A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines.
   Cancer. 2023;129:2671-2684.
   PubMed     Abstract available
   
   
   
10. MACKINNON KM, Risica PM, von Ash T, Scharf AL, et al
    Barriers and motivators to women's cancer screening: A qualitative study of a sample of diverse women.
    Cancer. 2023;129.
    PubMed     Abstract available
    
    
    June 2023
11. FRANCO EL
    The time has come to implement primary human papillomavirus screening for cervical cancer in the United States.
    Cancer. 2023 Jun 22. doi: 10.1002/cncr.34899.
    PubMed    
    
    
    May 2023
12. SPENCER JC, Noel L, Shokar NK, Pignone MP, et al
    Understanding the role of access in Hispanic cancer screening disparities.
    Cancer. 2023;129:1569-1578.
    PubMed     Abstract available
    
    
    April 2023
13. AYALA-PEACOCK DN, Chino JP
    Is it time for bone marrow sparing radiation therapy to be standard of care in cervical cancer?
    Cancer. 2023 Apr 12. doi: 10.1002/cncr.34769.
    PubMed    
    
    
    
14. WANG S, Liu J, Lei K, Jia Y, et al
    Single-photon emission computed tomography-defined active bone marrow-sparing volumetric-modulated arc therapy reduces the incidence of acute hematologic toxicity in locally advanced cervical cancer patients who receive chemoradiotherapy: A single-cen
    Cancer. 2023 Apr 12. doi: 10.1002/cncr.34771.
    PubMed     Abstract available
    
    
    
15. NIERENGARTEN MB
    Balancing the benefits and harms of cervical cancer screening in older women.
    Cancer. 2023;129:979-980.
    PubMed    
    
    
    January 2023
16. PODWIKA SE, Duska LR
    Top advances of the year: Cervical cancer.
    Cancer. 2023 Jan 7. doi: 10.1002/cncr.34617.
    PubMed     Abstract available
    
    
    October 2022
17. DUSKA LR
    Overcoming disparities to improve cancer care: The story of cervical cancer.
    Cancer. 2022 Oct 14. doi: 10.1002/cncr.34488.
    PubMed     Abstract available
    
    
    
18. VIKRAMAN SM, Khanna D, Dandpat A
    Cervical cancer elimination in indian context: Moving from barriers to facilitators.
    Cancer. 2022 Oct 14. doi: 10.1002/cncr.34486.
    PubMed     Abstract available
    
    
    
19. RIMEL BJ, Kunos CA, Macioce N, Temkin SM, et al
    Current gaps and opportunities in screening, prevention, and treatment of cervical cancer.
    Cancer. 2022 Oct 14. doi: 10.1002/cncr.34487.
    PubMed     Abstract available
    
    
    
20. MARKOVINA S, Rendle KA, Cohen AC, Kuroki LM, et al
    Improving cervical cancer survival-A multifaceted strategy to sustain progress for this global problem.
    Cancer. 2022 Oct 14. doi: 10.1002/cncr.34485.
    PubMed     Abstract available
    
    
    August 2022
21. MCDANIELS-DAVIDSON C, Feng CH, Martinez ME, Canchola AJ, et al
    Improved survival in cervical cancer patients receiving care at National Cancer Institute-designated cancer centers.
    Cancer. 2022 Aug 2. doi: 10.1002/cncr.34404.
    PubMed     Abstract available
    
    
    June 2022
22. O'ROURKE K
    Cemiplimab shines for recurrent cervical cancer.
    Cancer. 2022;128:2050-2051.
    PubMed    
    
    
    
23. JOUNG RH, Nelson H, Mullett TW, Kurtzman SH, et al
    A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Cancer. 2022;128:2119-2125.
    PubMed     Abstract available
    
    
    May 2022
24. STENZEL AE, Bustamante G, Sarkin CA, Harripersaud K, et al
    The intersection of sexual orientation with race and ethnicity in cervical cancer screening.
    Cancer. 2022 May 16. doi: 10.1002/cncr.34213.
    PubMed     Abstract available
    
    
    April 2022
25. O'ROURKE K
    Better HPV vaccination and cervical cancer screening needed.
    Cancer. 2022;128:1559.
    PubMed    
    
    
    February 2022
26. EKANAYAKE WEERAMANGE C, Shu D, Tang KD, Batra J, et al
    Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Cancer. 2022 Feb 17. doi: 10.1002/cncr.34148.
    PubMed     Abstract available
    
    
    November 2021
27. PEI J, Li M, Wu C, Xu M, et al
    Worldwide trends in cervical cancer incidence and mortality.
    Cancer. 2021 Nov 24. doi: 10.1002/cncr.34029.
    PubMed    
    
    
    
28. LIN S, Gao K, Jin M
    Reply to Worldwide trends in cervical cancer incidence and mortality.
    Cancer. 2021 Nov 24. doi: 10.1002/cncr.34031.
    PubMed    
    
    
    
29. DESAI S, Zhu MJ, Lapidos-Salaiz I
    Cervical cancer prevention: Human papillomavirus testing as primary screening.
    Cancer. 2021 Nov 12. doi: 10.1002/cncr.34006.
    PubMed     Abstract available
    
    
    October 2021
30. BRANDT HM, Kepka D, Kirchhoff AC, Daniel CL, et al
    Human papillomavirus (HPV) vaccination is cancer prevention for childhood cancer survivors.
    Cancer. 2021 Oct 4. doi: 10.1002/cncr.33920.
    PubMed    
    
    
    
31. NIERENGARTEN MB
    Study shows a decrease in cervical cancer but a rise in other human papillomavirus-related cancers.
    Cancer. 2021;127:3499.
    PubMed    
    
    
    
32. PINATTI LM, Gu W, Wang Y, Elhossiny A, et al
    SearcHPV: A novel approach to identify and assemble human papillomavirus-host genomic integration events in cancer.
    Cancer. 2021;127:3531-3540.
    PubMed     Abstract available
    
    
    August 2021
33. LIN S, Gao K, Gu S, You L, et al
    Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years.
    Cancer. 2021 Aug 9. doi: 10.1002/cncr.33795.
    PubMed     Abstract available
    
    
    July 2021
34. MIX JM, Saraiya M, Thompson TD, Querec TD, et al
    Prevalence of human papillomavirus genotypes in high-grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States.
    Cancer. 2021 Jul 21. doi: 10.1002/cncr.33582.
    PubMed     Abstract available
    
    
    May 2021
35. GARCIA-SOTO AE, McKenzie ND, Whicker ME, Pearson JM, et al
    Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer.
    Cancer. 2021 May 1. doi: 10.1002/cncr.33449.
    PubMed     Abstract available
    
    
    April 2021
36. PRINTZ C
    Lower Cervical Cancer Risk Associated With HPV Vaccine.
    Cancer. 2021;127:1171.
    PubMed    
    
    
    
37. TAIT SD, Ren Y, Horton CC, Oshima SM, et al
    Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women.
    Cancer. 2021 Apr 7. doi: 10.1002/cncr.33473.
    PubMed     Abstract available
    
    
    March 2021
38. BALACHANDRA S, Kusin SB, Lee R, Blackwell JM, et al
    Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
    Cancer. 2021;127:850-864.
    PubMed     Abstract available
    
    
    July 2020
39. SRIVASTAVA AJ, Contreras JA, Davis M, Markovina ST, et al
    Early posttherapy clearance of human papillomavirus and treatment response in cervical carcinoma.
    Cancer. 2020 Jul 8. doi: 10.1002/cncr.33040.
    PubMed     Abstract available
    
    
    April 2020
40. RODRIGUEZ AM, Zeybek B, Vaughn M, Westra J, et al
    Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study.
    Cancer. 2020;126:1656-1667.
    PubMed     Abstract available
    
    
    March 2020
41. SALCEDO MP, Sood AK, Jhingran A, Eifel PJ, et al
    Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women.
    Cancer. 2020 Mar 3. doi: 10.1002/cncr.32807.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.